Enforcement Report - Week of November 8, 2023
Amneal's Generic Valsartan & Hydrochlorothiazide Receives Approval in the U.S.
Macleods' Generic Olmesartan Medoxomil and Hydrochlorothiazide Receives Receives Approval in the U.S.
Enforcement Report - Week of January 25, 2023
New Delhi: Zydus Lifesciences on Tuesday said it has received approval from the US health regulator to market blood pressure lowering drug Bisoprolol Fumarate and Hydrochlorothiazide tablets in the American market. The company has received approval from the US Food and Drug Administration (USFDA) to market the generic medication in multiple strengths, the Ahmedabad-based drug maker said in a statement.
Cadila's Generic Bisoprolol Fumarate, Hydrochlorothiazide Receives Approval in the U.S.
Enforcement Report - Week of November 2, 2022
Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Recall of Two (2) Lots of Quinapril and Hydrochlorothiazide
Enforcement Report - Week of August 17, 2022
Enforcement Report - Week of April 13, 2022